InvestorsHub Logo
Followers 3
Posts 789
Boards Moderated 0
Alias Born 01/10/2010

Re: None

Wednesday, 03/17/2010 2:07:24 PM

Wednesday, March 17, 2010 2:07:24 PM

Post# of 48
Quote:
--------------------------------------------------------------------------------
BioTime, Inc. Reports Peer-Reviewed Scientific Publication on the Reversal of the Developmental Aging of Normal Human Cells
Paper and Related Patent Filings Are a Strategic Step Forward in the Development of the Company’s ReCyte™ iPS Technology

BioTime, Inc. (NYSE Amex:BTIM), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced the publication of a scientific paper titled "Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming." The article was released online today in the peer-reviewed journal Regenerative Medicine in advance of the print publication. The demonstration that the aging of human cells can be reversed may have significant implications for the development of new classes of cell-based therapies targeting age-related degenerative disease. The on-line version of the article can be found at http://ih.advfn.com/p.php?pid=nmona&cb=1268849409&article=41984088&symbol=A%5EBTIM

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.